ArticleTargeted oncology2020

Co-Regulation of Immune Checkpoint PD-L1 with Interferon-Gamma Signaling is Associated with a Survival Benefit in Renal Cell Cancer.

Jörg Hänze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.